COMBI — Combigene AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK76.23m
- -SEK25.21m
- SEK5.54m
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | Interim Report | ARS | ARS | PRESS |
Standards: | SAS | — | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -17.7 | — | 21 | -6.95 | — |
Amortisation | |||||
Non-Cash Items | 1.17 | — | — | -11.7 | — |
Other Non-Cash Items | |||||
Changes in Working Capital | -5.08 | -38.3 | -1.44 | -0.614 | -30.6 |
Change in Accounts Receivable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -21.6 | -38.3 | 22.1 | -16.7 | -30.6 |
Capital Expenditures | 0 | — | -0.148 | 0 | — |
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -1.52 | -0.104 | 0 | — | -0.994 |
Acquisition of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.52 | -0.104 | -0.148 | 0 | -0.994 |
Financing Cash Flow Items | -0.12 | 72.2 | — | — | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 6.49 | 72.2 | 65.9 | 0 | 0 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -16.6 | 33.7 | 87.8 | -4.97 | -30.3 |